Neumora Therapeutics Inc (NASDAQ: NMRA) on Monday, plunged -10.07% from the previous trading day, before settling in for the closing price of $1.49. Within the past 52 weeks, NMRA’s price has moved between $1.30 and $21.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 4.29%. With a float of $56.00 million, this company’s outstanding shares have now reached $161.71 million.
The extent of productivity of a business whose workforce counts for 110 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Neumora Therapeutics Inc (NMRA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Neumora Therapeutics Inc is 65.43%, while institutional ownership is 37.28%. The most recent insider transaction that took place on Feb 18 ’25, was worth 23,468. In this transaction an insider of this company sold 13,871 shares at a rate of $1.69, taking the stock ownership to the 7,405,004 shares. Before that another transaction happened on Feb 18 ’25, when Company’s insider sold 1,978 for $1.69, making the entire transaction worth $3,351. This insider now owns 22,470 shares in total.
Neumora Therapeutics Inc (NMRA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 4.29% per share during the next fiscal year.
Neumora Therapeutics Inc (NASDAQ: NMRA) Trading Performance Indicators
Neumora Therapeutics Inc (NMRA) is currently performing well based on its current performance indicators. A quick ratio of 10.51 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.53, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.23 in one year’s time.
Technical Analysis of Neumora Therapeutics Inc (NMRA)
The latest stats from [Neumora Therapeutics Inc, NMRA] show that its last 5-days average volume of 1.23 million was inferior to 4.0 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 30.74%. Additionally, its Average True Range was 0.19.
During the past 100 days, Neumora Therapeutics Inc’s (NMRA) raw stochastic average was set at 0.25%, which indicates a significant decrease from 7.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.36% in the past 14 days, which was lower than the 275.91% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.7956, while its 200-day Moving Average is $9.2848. Now, the first resistance to watch is $1.4400. This is followed by the second major resistance level at $1.5400. The third major resistance level sits at $1.6000. If the price goes on to break the first support level at $1.2800, it is likely to go to the next support level at $1.2200. The third support level lies at $1.1200 if the price breaches the second support level.
Neumora Therapeutics Inc (NASDAQ: NMRA) Key Stats
Market capitalization of the company is 217.05 million based on 161,979K outstanding shares. Right now, sales total 0 K and income totals -235,930 K. The company made 0 K in profit during its latest quarter, and -72,550 K in sales during its previous quarter.
